Pfizer · NSE: PFIZER · BSE: 500680
Q2 FY23 results · Jul–Sep 2022
Pfizer reported revenue from operations of ₹637.47 crore (up 0.2% from Q2 FY22) and net profit of ₹311.07 crore (up 117.6% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a standalone basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 637.47 | 636.26 | +0.2% | 592.90 | +7.5% |
| Other income | 24.24 | 15.03 | +61.3% | 18.02 | +34.5% |
| Total income | 661.71 | 651.29 | +1.6% | 610.92 | +8.3% |
| Profit before tax | 415.22 | 174.96 | +137.3% | 43.39 | +856.9% |
| Net profit for the period | 311.07 | 142.95 | +117.6% | 32.55 | +855.7% |
| EPS, basic (₹) | 67.99 | 31.25 | +117.6% | 7.11 | +856.3% |
| Net margin (%) | 48.8 | 22.5 | 5.5 |
Standalone
- Filed with BSE
- 11 Nov 2022, 17:56 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE